Registry for blood-clot prevention plans in arterial antiphospholipid syndrome
Treatments studied
Part of Brain & nervous system, Heart & circulation, Immune system & allergy clinical trials.
This study keeps a registry to follow people with antiphospholipid syndrome (APS) who have had arterial blood clots (like stroke). It collects information about the treatment approach your clinician chooses to see how different antithrombotic regimens may perform and be tolerated.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be age 18 or older and have confirmed antiphospholipid syndrome (APS) by Sydney criteria
- Have had an arterial blood clot event in the past (or an imaging finding of brain infarct without symptoms)
- Be taking a blood thinner plan your clinician considers appropriate, such as warfarin-like medication (INR in a target range) plus or minus aspirin, or a dual antiplatelet regimen
- Be able to take part in follow-up/visits as the study needs (not blocked by location or other practical issues)
- Be willing to sign informed consent (where required)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study keeps an international registry of people with antiphospholipid syndrome (APS) who are taking direct oral blood thinners. It may help doctors better understand how APS patients do over time and improve future care, even if you’re not asked to change treatment.
This study is for children who have antiphospholipid syndrome (APS) and a history of blood vessel clots. Researchers want to learn more about APS in pediatric patients who have specific blood test signs and clot history.
This study compares two types of blood thinners (vitamin K antagonists) in people with antiphospholipid syndrome, a condition where the immune system attacks healthy cells and increases blood clot risk. The goal is to see if one is better at preventing future blood clots.
This study looks at how platelet counts change over time in people with antiphospholipid syndrome (APS), a condition that can cause blood clots and pregnancy problems. It may help doctors better understand and manage low platelets in APS patients.
This study looks at genetic (inherited) risk factors in people who have antiphospholipid antibodies and related symptoms. Your results may help researchers better predict who is at risk and improve care for antiphospholipid antibody syndrome.
This study looks at lab results and clinic information in people who have antiphospholipid antibodies. The goal is to better understand these antibody-positive conditions and what happens over time, which may help improve care.
Hear when a new Antiphospholipid Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.